None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Subjects whose are 40 <= years old < 65. (2) Subjects who can visit hospital on designated day. (3) Subject who is able to give written informed consent before the study.
Exclusion criteria
Exclusion criteria: (1) Subjects whose systolic blood pressure is less than 90mmHg (2) Females who are pregnant or lactating, and females who could become pregnant or lactating during test period (3) Subjects who donated 200 mL of blood and/or blood components within four weeks prior to the current study (4) Males whose blood was collected more than 400 mL within the last 12 weeks (5) Females whose blood was collected more than 400 mL within the last 16 weeks (6) Males whose blood was collected more than 1200 mL within the last twelve months when the amount of blood sampling in the current study is added (7) Females whose blood was collected more than 800 mL within the last twelve months when the amount of blood sampling in the current study is added (8) Subjects who are participating in other clinical studies for drug medicine or food, or who finished clinical study within four weeks (9) Subjects who drink alcohol a lot (10) Subjects who have a habit of smoking (11) Subjects who are with treatment (12) Subjects who constantly use drug medicine (13) Subjects who are judged as unsuitable for the study by the principal investigator for other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood inflammatory marker | — |
Countries
Japan
Contacts
SUNTORY GLOBAL INNOVATION CENTER LIMITED Research Institute